Hormonfreie Hilfe bei Scheidentrockenheit für Frauen nach Brustkrebs

ZUSAMMENFASSUNG

Nach einer hormonablativen Brustkrebstherapie leiden 70% der Frauen unter Scheidentrockenheit, Libidoverlust und eingeschränkter Lebensqualität. Wegen der unklaren Datenlage zur allgemeinen und lokalen hormonellen Therapie in dieser Situation werden in diesem Beitrag hormonfreie Alternativen vorgestellt, die auf Basis von Pflanzenextrakten hautpflegende und regenerierende Eigenschaften aufweisen. Ein Sanddornöl-Spezialextrakt kann oral verabreicht werden. Bei den pflanzlichen Vaginaltherapeutika ist darauf zu achten, dass sie nicht nur befeuchten, sondern die Schleimhaut pflegen. Individuelle Rezepturarzneimittel können in darauf spezialisierten Apotheken hergestellt werden.

Abstract

Treatment of breast cancer patients with aromatase inhibitors often lead to vaginal dryness, sexual dysfunction and impairment of quality of life. The use of systemic or topical hormone therapy is contraindicated for breast cancer patients. In this article we represent alternative treatments without hormones, mainly based on plant extracts which improve the integrity of the vaginal epithelium. An extract of sea buckthorn oil can be administered orally. For the topical treatment different plant derived formulas are recommended instead of simple vaginal moisturizers. Individual prescription drugs may be manufactured in specialized pharmacies.

Schlüsselwörter

Brustkrebs - Lebensqualität - Scheidentrockenheit - supportive Therapie - antihormonelle Therapie

Key words

Breast cancer - quality of life - vaginal dryness - supportive therapies - antihormonal therapy

• Literatur

• 1 Hersant B. et al. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause 2018; 25: 1124-1130
• 2 Witherby S. et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist 2011; 16: 424-431
• 3 Barton DL. et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 2018; 26: 643-650
• 4 Pfeiler G. et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients. Climacteric 2011; 14: 339-344
• 5 Le Ray I. et al. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study. Breast Cancer Res Treat 2012; 135: 603-609
• 6 Larmo PS. et al. Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: a randomized, double-blind, placebo-controlled study. Maturitas 2014; 79: 316-321
• 7 Kimura Y. et al. Restoration of tear secretion in a murine dry eye model by oral administration of palmitoleic acid. Nutrients 2017; 9 pii: E364
• 8 Diandong H. et al. Sea buckthorn (Hippophae rhamnoides L.) oil protects against chronic stress-induced inhibitory function of natural killer cells in rats. Int J Immunopathol Pharmacol 2016; 29: 76-83
• 9 Olas B, Skalski B, Ulanowska K. The anticancer activity of sea buckthorn [Elaeagnus rhamnoides (L.) A. Nelson]. Front Pharmacol 2018; 9: 232
• 10 Vashishtha V. et al. Effect of seabuckthorn seed oil in reducing cardiovascular risk factors: A longitudinal controlled trial on hypertensive subjects. Clin Nutr 2017; 36: 1231-1238
• 11 Juraskova I. et al. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med 2013; 10: 2549-2558